Openning ceremony is held to celebrate the public listing of Haisco, Tibet's 11th company on Shenzhen Stock Exchange on Jan.17. [Photo/Xzsn.com]

The Xizang Haisco Pharmaceutical Group Co. Ltd.(SZSE:002653) based in Tibet's Shannan Prefecuture went public Tuesday, becoming the 11th listed company in the underdeveloped plateau region, according to a Xinhua report.

Haisco started trading on the SME (small and medium-sized enterprises) Board on the Shenzhen Stock Exchange, with 40.1 million shares issued at a price of 20 yuan (3.17 U.S. dollars) per share.

The seven-year-old Pharm company mainly produces high-end parenteral nutrition medicine, hepatic and cholalic disease medicine and anti-infection medicine.

Securities regulatory authorities and local goverment said that the case of Haisco would encourage more local companies to go public, which fits the central government's call for active support towards the listing of indigenous enterprises.

"That is an important job for us in the next few years," said Dorje Tsering, vice chairman of the Tibet regional government.